Accounts Payable, Current of Universe Pharmaceuticals INC from 30 Sep 2020 to 30 Sep 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
- Summary
-
Universe Pharmaceuticals INC quarterly Accounts Payable, Current in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
- Universe Pharmaceuticals INC Accounts Payable, Current for the quarter ending 30 Sep 2025 was $1,669,785,000, a 33875% increase year-over-year.
- Source SEC data
- View on sec.gov
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)
Universe Pharmaceuticals INC Quarterly Accounts Payable, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | $1,669,785,000 | +$1,664,870,238 | +33875% | 30 Sep 2025 | 20-F | 29 Jan 2026 | 2025 | FY |
| Q3 2024 | $4,914,762 | +$329,479 | +7.2% | 30 Sep 2024 | 20-F | 29 Jan 2026 | 2025 | FY |
| Q1 2024 | $7,763,981 | -$3,475,044 | -31% | 31 Mar 2024 | 6-K | 20 Sep 2024 | 2024 | Q2 |
| Q3 2023 | $4,585,283 | +$1,509,890 | +49% | 30 Sep 2023 | 20-F | 29 Apr 2025 | 2024 | FY |
| Q1 2023 | $11,239,025 | +$7,593,582 | +208% | 31 Mar 2023 | 6-K | 31 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $3,075,393 | -$2,235,133 | -42% | 30 Sep 2022 | 20-F | 30 Jan 2024 | 2023 | FY |
| Q1 2022 | $3,645,443 | 31 Mar 2022 | 6-K | 16 Aug 2022 | ||||
| Q3 2021 | $5,310,526 | +$2,619,333 | +97% | 30 Sep 2021 | 20-F | 10 Feb 2023 | 2022 | FY |
| Q3 2020 | $2,691,193 | 30 Sep 2020 | 20-F | 31 Jan 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.